Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Assets (2020 - 2025)

Agilon Health's Assets history spans 6 years, with the latest figure at $1.3 billion for Q4 2025.

  • For Q4 2025, Assets fell 26.68% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, down 26.68%, while the annual FY2025 figure was $1.3 billion, 26.68% down from the prior year.
  • Assets reached $1.3 billion in Q4 2025 per AGL's latest filing, down from $1.6 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $2.4 billion in Q2 2023 to a low of $574.0 million in Q1 2021.
  • Average Assets over 5 years is $1.8 billion, with a median of $1.8 billion recorded in 2022.
  • Peak YoY movement for Assets: skyrocketed 255.37% in 2021, then decreased 26.68% in 2025.
  • A 5-year view of Assets shows it stood at $1.6 billion in 2021, then increased by 7.01% to $1.7 billion in 2022, then rose by 2.56% to $1.7 billion in 2023, then fell by 0.4% to $1.7 billion in 2024, then decreased by 26.68% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for AGL's Assets are $1.3 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.7 billion (Q2 2025).